Featured Research

from universities, journals, and other organizations

Discovery could help stem smoking-related diseases

Date:
January 16, 2012
Source:
University of Melbourne
Summary:
Sufferers of smoking-related lung diseases could have their debilitating symptoms reduced following the discovery of a potential new treatment.

Sufferers of smoking related lung diseases could have their debilitating symptoms reduced following the discovery of a potential new treatment.

The discovery, by researchers at the University of Melbourne, Royal Melbourne Hospital, Australia, and the Brigham and Women's Hospital, Harvard Medical School, US, could dramatically improve treatments and slow the progression of COPD (Chronic Obstructive Pulmonary Disease) which includes the incurable condition emphysema.

COPD is a progressive disease that makes it hard to breathe and is mostly caused by excessive smoking. Approximately 2.1 million Australians have some form of COPD. By 2050, this figure is expected to more than double to 4.5 million.

The international team identified that the protein SAA plays a key role in chronic inflammation and lung damage in COPD and also inhibits the natural effort of the lung to repair itself after smoking has stopped.

The findings have been published in the Proceedings of National Academy of Science.

Professor Gary Anderson from the University of Melbourne said the discovery could become a dual treatment to improve lung function at any stage of COPD.

"It has the potential to dramatically improve the lives of many people suffering these conditions and reduce the huge burden of health and hospital costs associated with their treatment," he said.

Lead author Associate Professor Steven Bozinovski from the University of Melbourne said the findings were significant because SAA was normally made in the liver, but they found that very high levels were made in the lungs of COPD patients. "It was a breakthrough for us to confirm that SAA played such a key role in the lung," he said.

The team confirmed that SAA not only caused inflammation but hindered natural healing in the lung.

Harvard's Associate Professor Bruce Levy said, they found that as the SAA interacted with its receptor it not only triggered lung inflammation, it also stopped a natural healing molecule which helped to turn off inflammation and heal the lung.

"This mechanism appears to explain one of the reasons that inflammation in COPD just never resolves despite stopping smoking," he said.

The discovery could lead to the development of a dual treatment by firstly, targeting SAA to switch off its function in the lung and secondly, adding a synthetic form of the natural healing agent to boost lung healing. Clinical development for the synthetic agent is currently under way in the US.

The proposed combined treatment could also improve the effectiveness of steroid treatment for COPD, which is effective in treating other lung diseases such as asthma.

"Steroid treatments work in conditions like asthma by turning off the production of inflammatory substances; however, our latest finding reveals that steroids actually fail to block the production of SAA and hence inflammation in the lung," Professor Anderson said.

"We believe SAA plays a critical role in why steroids are much less effective than they should be in treating COPD," he said.

It is hoped the new treatment will go to clinical trial within the next seven years.

"This is not a golden ticket to smoke," he said. "We are hopeful the combined treatment will assist patients of all stages of COPD, particularly those in stage four with constant hospital visits, to improve their quality of life, but it would not cure disease," he said.

He said the only way to prevent COPD is not to smoke. "If you are currently smoking the best thing to do is to quit as this will prevent the worsening of COPD," he said.

The research was funded in part by the National Health and Medical Research Council (Australia) and the National Institute of Health (US).


Story Source:

The above story is based on materials provided by University of Melbourne. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. Bozinovski, M. Uddin, R. Vlahos, M. Thompson, J. L. McQualter, A.-S. Merritt, P. A. B. Wark, A. Hutchinson, L. B. Irving, B. D. Levy, G. P. Anderson. Serum amyloid A opposes lipoxin A4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proceedings of the National Academy of Sciences, 2012; DOI: 10.1073/pnas.1109382109

Cite This Page:

University of Melbourne. "Discovery could help stem smoking-related diseases." ScienceDaily. ScienceDaily, 16 January 2012. <www.sciencedaily.com/releases/2012/01/120112100627.htm>.
University of Melbourne. (2012, January 16). Discovery could help stem smoking-related diseases. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/01/120112100627.htm
University of Melbourne. "Discovery could help stem smoking-related diseases." ScienceDaily. www.sciencedaily.com/releases/2012/01/120112100627.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins